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Interictal FDG-PET (iPET) is a core tool for localizing the epileptogenic focus, potentially
before structural MRI, that does not require rare and transient epileptiform discharges
or seizures on EEG. The visual interpretation of iPET is challenging and requires years of
epilepsy-specific expertise. We have developed an automated computer-aided diagnos-
tic (CAD) tool that has the potential to work both independent of and synergistically with
expert analysis. Our tool operates on distributed metabolic changes across the whole brain
measured by iPET to both diagnose and lateralize temporal lobe epilepsy (TLE). When diag-
nosing left TLE (LTLE) or right TLE (RTLE) vs. non-epileptic seizures (NES), our accuracy
in reproducing the results of the gold standard long term video-EEG monitoring was 82%
[95% confidence interval (CI) 69–90%] or 88% (95% CI 76–94%), respectively. The clas-
sifier that both diagnosed and lateralized the disease had overall accuracy of 76% (95%
CI 66–84%), where 89% (95% CI 77–96%) of patients correctly identified with epilepsy
were correctly lateralized. When identifying LTLE, our CAD tool utilized metabolic changes
across the entire brain. By contrast, only temporal regions and the right frontal lobe cortex,
were needed to identify RTLE accurately, a finding consistent with clinical observations
and indicative of a potential pathophysiological difference between RTLE and LTLE. The
goal of CADs is to complement – not replace – expert analysis. In our dataset, the accu-
racy of manual analysis (MA) of iPET (∼80%) was similar to CAD. The square correlation
between our CAD tool and MA, however, was only 30%, indicating that our CAD tool does
not recreate MA.The addition of clinical information to our CAD, however, did not substan-
tively change performance. These results suggest that automated analysis might provide
clinically valuable information to focus treatment more effectively.
Keywords: epilepsy, computer-aided diagnosis, mutual information, temporal lobe epilepsy, PET,
fluoro-deoxyglucose positron emission tomography, machine learning
INTRODUCTION
It is difficult to differentiate between patients with epilepsy (PWE),
and those with non-epileptic seizures (NES). The clinical assess-
ment relies on the report of untrained witnesses or the patients
themselves. A non-epileptic seizure is defined as the presence of
external seizure symptoms and/or signs with no electrographic
features characteristic of epilepsy. Long term video-EEG moni-
toring has shown consistently that roughly one third of patients
diagnosed with “medication refractory epilepsy” in fact suffer
from NES (Kerr et al., 2012a). Because they don’t suffer from
epilepsy, these patients with NES (PWN) are not treated effec-
tively with anti-epileptic drugs (AEDs). For the majority of PWN,
the NES are a manifestation of dissociative or conversion disor-
der in which their psychological challenges manifest themselves
physically (Marchetti et al., 2008, 2009). A minority of PWN suf-
fers from organic, non-epileptic maladies that can be confused
with seizure disorder including, but not limited to, dementia
and cardiovascular disease (Sahaya et al., 2011). The gold stan-
dard for the differential diagnosis and pre-surgical assessment
of epilepsy includes 72 or more hours of video-EEG monitor-
ing (Cragar et al., 2002; LaFrance and Devinsky, 2004). How-
ever, 10% of patients admitted for this extensive assessment
leave with inconclusive results (Kerr et al., 2012a). Considering
that one sixth of PWE are diagnosed with medication refractory
epilepsy (Privitera, 2011), improved methods to effectively iden-
tify PWN who do not benefit from AEDs effectively could reduce
the morbidity and both the financial and social cost of treating
epilepsy.
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Improved diagnostic tools could also help PWE. The diffi-
culty in ruling out non-epileptic etiologies speaks to the chal-
lenge of adequately localizing and characterizing each patient’s
epileptic etiology. The major seizure type discriminations are
focal vs. generalized; partial vs. complex; and lesional vs. non-
lesional. Each of these key discriminations leads patients down a
different treatment path. When medication or other novel treat-
ments like the vagus nerve stimulator fails, as they frequently
do, the patient is left to consider resective neurosurgery. Recent
reports have shown that surgery is most effective earlier in the
course of disease (Engel et al., 2012). Improved diagnostic tools
could more quickly and effectively diagnose patients with epileptic
seizures and therefore speed the progression toward considering
the surgical option.
Ultimately, our goal is to establish a general, automated
computer-aided diagnostic (CAD) tool that effectively combines
clinical information, manual interpretation of EEG and imaging
technologies as well as automated analysis of interictal FDG-PET
(iPET), EEG, structural MRI (sMRI), and diffusion MRI for all
subtypes of epilepsy and NES. To accomplish this, we first must
develop effective CAD tools that harness the information from
each modality for a limited set of epileptic localizations. We have
begun already to address automated analysis of interictal EEG for
a wide variety of epilepsy subtypes (Kerr et al., 2012a). Others have
described effective CAD tools that diagnose and lateralize tempo-
ral lobe epilepsy (TLE) using structural and diffusion MRI (Farid
et al., 2012; Focke et al., 2012; Keihaninejad et al., 2012).
The clinical, metabolic, and structural differences between left
and right TLE can be subtle. Some theories suggest that TLE is
inherently a bilateral disease. Potentially, due to the strong func-
tional link between the hippocampi, the only clinical difference
is that in the aura of patient with left TLE (LTLE) more fre-
quently includes language dysfunction. Over time, patients with
LTLE more commonly develop verbal memory deficits, compared
to non-verbal memory deficits in right TLE (RTLE) (Delaney et al.,
1980; Kim et al., 2003). This functional connection between the
hippocampi may also lead some patients to be falsely-lateralized
using scalp EEG because a small seizure onset zone (SOZ) in one
hippocampus can induce larger scale ictal activity in the con-
tralateral hippocampus with very little time delay. This can lead
neurologists to falsely conclude that the SOZ is either bilateral or in
the contralateral hippocampus. Structural and metabolic imaging
can reduce these errors by demonstrating that that one temporal
lobe is asymmetrically affected, as shown by the previous CAD
tools that lateralize TLE (Farid et al., 2012; Focke et al., 2012;
Keihaninejad et al., 2012). Studies of the functional connectivity
of these epileptic networks, however, conclude that there are very
few, if any, differences between the two lateralizations (Zhang et al.,
2010; Liao et al., 2011; Morgan et al., 2011, 2012; Pittau et al., 2012;
McCormick et al., 2013). Recently, Pereira et al. (2010) suggested
that more patterns of functional connectivity change in LTLE
compared to RTLE. However, after patients suffer from intractable
seizures for 10 or more years, the intrahemispheric hippocampal
connectivity linearly increases with the duration of disease, sug-
gesting that over time lateralized disease may become bilateral
disease (Morgan et al., 2011). Because patients with bilateral hip-
pocampal disease are no longer considered surgical candidates,
improved methods to distinguish left and right TLE early in the
course of disease are needed.
In this manuscript, we discuss the development of an auto-
mated CAD tool to diagnose, and lateralize, TLE using iPET. We
also begin to address how to combine our CAD tool with manual
analysis (MA) and incorporate it into clinical practice. Using a
mutual information-based feature selection technique, we exam-
ine how our methods reveal more about the distributed metabolic
abnormalities that are associated with the different anatomical
locations of the epileptogenic focus.
The realistic goal of CAD tools is to complement, not to replace,
expert analysis. Therefore, we focus on how clinical information
and expert analysis can work synergistically with our automated
technology. To summarize the major clinical differences, patients
with NES are characteristically females in the third decade of
life with psychiatric co-morbidities (Sahaya et al., 2011). PWE,
however, also have significant psychiatric co-morbidities includ-
ing potentially reduced financial and social independence due
to the suspension of their driver’s and, frequently, professional
license. Particularly in adult onset epilepsy, age-associated changes
in metabolism may confound the interpretation of iPET, possibly
leading to an increased diagnostic uncertainty. It is well estab-
lished that 80–90% of medication refractory epilepsy is “PET
positive” (Salamon et al., 2008; Lee and Salamon, 2009).The rate
of PET positivity in NES has not been studied extensively, there-
fore the true positive predictive value of iPET is unclear. Although
these differences in clinical presentation are salient, their quanti-
tative effect on diagnostic probabilities is unknown. Therefore,
we also examined how simple clinical information and expert
manual interpretation can be incorporated into our quantitative
CAD tool.
The standard of care for the pre-surgical assessment for epilepsy
is the manual correlation of iPET with numerous other diagnostic
modalities. The goal of this assessment is to simultaneously ver-
ify the diagnosis of epilepsy, characterize the seizure etiology, and
identify the location and extent of the SOZ. Expert radiologists
and neurologists can detect metabolic asymmetries indicative of
the epileptogenic focus or foci (Person et al., 2010). The exact
threshold at which asymmetric metabolism is attributed to patho-
logic change or seen as a variant of normal is part of the art of
neuroradiology (Benbadis et al., 2000; Reuber et al., 2002). Once
non-epileptic etiologies have been ruled out, our previous work
demonstrated that the quantitative degree of metabolic asymme-
try is correlated with surgical outcome (Lin et al., 2007). Surgical
outcome is improved further when iPET is co-registered to sMRI
because of improved characterization of the focus or foci (Chan-
dra et al., 2006; Rastogi et al., 2008; Salamon et al., 2008; Lee and
Salamon, 2009). These hypometabolic lesions are thought to be
secondary to increased inhibitory neuron cell death, gliosis, and
abnormal functional connectivity resulting in altered functional
metabolism.
The size of the hypometabolic lesion tends to be larger than
the SOZ, potentially due to functional changes in nearby tis-
sue secondary to the presence of the epileptogenic lesion (Juhasz
et al., 1999; Matheja et al., 2001; Henry and Roman, 2011). Such
reports are major limitations to the wide implementation of iPET
in epilepsy practices (Barrington et al., 1998; So et al., 2000; Henry
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et al., 2011). In addition to the limitation of counting statistics,
that forces the quantitative radioactivity intensity of iPET to be
less certain in hypometabolic lesions (Kerr and Lau, 2012), the
biological hypothesis is that the epileptogenic abnormality induces
metabolic abnormality at the SOZ and also at closely associated
and/or functionally connected regions (Henry et al., 1990, 1993;
Sperling et al., 1990; Sadzot et al., 1992; Arnold et al., 1996; Dlugos
et al., 1999; Bouilleret et al., 2002; Rusu et al., 2005; Nelissen et al.,
2006; Takaya et al., 2006; Lee et al., 2009). The epileptogenic lesion
commonly is larger and more diffuse in left TLE then right TLE,
potentially because of the high degree of functional connectivity
between specialized foci within the left temporal lobe associated
with language and other functions (Toga and Thompson, 2003;
Barrick et al., 2005; Iturria-Medina et al., 2011; Haneef et al., 2012;
Kucyi et al., 2012). These insights parallel the trend in dementia
that atrophy starts focally then spreads more quickly to function-
ally connected regions (Zhou et al., 2012). The limited sensitivity
of iPET unaligned with sMRI to characterize extratemporal lesions
may be partly due to the insufficient description of the local func-
tional network of each extratemporal focus and thereby reduced
detection of a characteristic pattern of metabolic abnormalities
associated with each focus. In general, an improved insight into
the clinical interpretation and value of metabolic abnormalities
outside the SOZ is needed. To overcome this limitation, the iPET
analysis is used in combination with other diagnostic modalities
determine which tissue to resect.
Clinical description, EEG, MRI, and FDG-PET each describe
separate facets of the pathophysiological etiology, and therefore all
play critical roles in the diagnosis of epilepsy, and in the identifica-
tion of the epileptogenic lesion (Struck et al., 2011). Each modality,
however, also has unique limitations. EEG provides an in-depth
description of the seizures and interictal epileptiform spikes. These
seizures and spikes, however, are rare events: only 50% of PWE
exhibit diagnostic interictal epileptiform spikes and/or seizure
activity during the first outpatient scalp EEG (Gilbert et al., 2003).
The characteristic signs of epilepsy in structural and diffusion MRI
may not be measurable until years after the first seizure because
these methods require the detection of atrophic tissue and/or sub-
tle regions of cortical dysplasia (Swartz et al., 1992; Reutens et al.,
1996; Van Paesschen et al., 1998; Liu et al., 2002; Jung da and
Lee, 2010; Bernasconi et al., 2011; Schmidt and Pohlmann-Eden,
2011; Dabbs et al., 2012). MA uses the contralateral structure to
assess if atrophy is present but a certain degree of asymmetry is
expected (Farid et al., 2012; Keihaninejad et al., 2012). It takes
years of specific experience in manually analyzing sMRIs from
PWE to reliably discriminate between normal variation and patho-
logic changes. Once these relatively large-scale changes in neural
structure have occurred, it is less likely that both invasive and non-
invasive treatments will be effective (Engel et al., 2012). iPET can
localize the epileptogenic lesion without observing rare events and,
potentially, before changes are detectible on sMRI and/or diffusion
tensor imaging (DTI) (Theodore et al., 1990; Ryvlin et al., 1991;
Swartz et al., 1992; Gaillard et al., 1995; Debets et al., 1997; Knowl-
ton et al., 1997, 2008; Blum et al., 1998; Drzezga et al., 1999;
Benedek et al., 2004; Carne et al., 2004; Chandra et al., 2006;
Yun et al., 2006; Uijl et al., 2007; Willmann et al., 2007; Rastogi
et al., 2008; Salamon et al., 2008; Duncan, 2009; Lee and Salamon,
2009; Lerner et al., 2009; Liew et al., 2009; Brodbeck et al., 2010;
Chinchure et al., 2010; Kim et al., 2011; Jupp et al., 2012). As
discussed above, the presence of metabolic abnormalities outside
the SOZ, however, complicates the effective localization of the
SOZ using iPET alone (Henry and Roman, 2011). An improved
description of these induced changes outside the SOZ may help
spare healthy tissue from resective surgery. Given the recent report
that resective neurosurgery for epilepsy is more effective earlier in
disease (Engel et al., 2012); we believe that iPET may play a crit-
ical role in characterizing patients with unremarkable MRIs and
inconclusive EEGs earlier in the course of their disease.
MATERIALS AND METHODS
PATIENT DATA
All of the 105 patients that were included in our analysis were
admitted to the University of California, Los Angeles (UCLA)
Seizure Disorder Center’s video-EEG Epilepsy Monitoring Unit
(EMU) between 2005 and 2012. Each patient’s diagnosis was
based on a consensus panel review of their clinical history, phys-
ical and neurological exam, neuropsychiatric testing, video-EEG,
iPET, ictal FDG-PET, structural and diffusion MRI, and/or CT
scan. This multimodal assessment is the gold standard for epilepsy
diagnosis and localization of the epileptic focus (Cragar et al.,
2002; LaFrance and Devinsky, 2004). The patients included in
this analysis were chosen because they had an FDG-PET after
2005; had no history of penetrative neurotrauma, including neuro-
surgery; were determined by consensus diagnosis to have a single,
lateralized epileptogenic focus; and had no suspicion of mixed
non-epileptic and epileptic seizure disorder. These patients were
diagnosed either with LTLE (n= 39), right TLE (RTLE,n= 34), or
NES (NES, n= 32). PET images were determined to be interictal
by clinical findings and concurrent scalp EEG.
PET and MRI images were acquired according to the best clin-
ical practices at the time of acquisition. PET/CT studies were
acquired using a Siemens Biograph scanner. After a minimum fast-
ing period of 6 h, patients received 0.14 mCi/kg of 18F-FDG-PET
intravenously. During the ensuing 40 min uptake period with con-
comitant EEG monitoring to confirm interictal status, the patients
waited in a quiet, dimply lit room with their eyes open. PET images
were reconstructed with an iterative algorithm (OSEM: 2 itera-
tions, 8 subsets). CT images were reconstructed using filtered back
projection at 3.4 mm axial intervals to match the slice separation
of the PET data, and used for attenuation correction.
COMPUTER-AIDED DIAGNOSTIC TOOL TRAINING AND VALIDATION
Automated analysis of the iPET records was performed in four
stages. (1) First, each image was screened for gross structural
and/or metabolic abnormalities by S.T.N., N.M.R., and/or W.T.K.
(n= 21). These excluded subjects are not reflected in the sam-
ple sizes quoted above. (2) NeuroQ (Syntermed, GA, USA) was
used to segment each brain into 47 regions of interest (ROIs) and
then to calculate the average radioactivity in each ROI, normal-
ized by the whole brain radioactivity (Table A1 in Appendix). (3)
The minimum redundancy-maximum relevancy (mRMR) tool-
box for MATLAB (Mathworks, MA, USA) was used to generate a
ranked list of the ROI metabolisms (features) within each train-
ing set that were maximally relevant to the diagnosis of epilepsy
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and minimally redundant with all higher ranked features (Ding
and Peng, 2005; Peng et al., 2005). The representative number of
features to exclude and quantal levels was selected based on our
method discussed previously (Kerr et al., 2012a,b) (see below).
In each of the training sets, the feature ranking was determined
exclusive of the test patient’s data. We expect the ranked lists to
be similar, but not identical, across training sets. For purely illus-
trative purposes, the full dataset was used to create the ranked
list in Table 2. (4) Weka was used to implement leave-one-out
cross-validation of a cost-sensitive Multilayer Perceptron (MLP)
that was weighted to maximize balanced accuracy, defined by the
mean of sensitivity and specificity (Bouckaert et al., 2010). Using
this method, we examined our ability to diagnose either LTLE or
RTLE from NES and assessed our ability to diagnose and lateralize
disease simultaneously. For the remainder of this manuscript, the
latter tool that discriminates LTLE vs. RTLE vs. NES is called the
trinary classifier. Similarly, the binary CAD tools are referred to by
the laterality of epilepsy that is being detected. The comparison
to NES is not stated, but can be assumed. We then compared our
CAD tool’s performance to the results of MA alone.
MACHINE LEARNING ALGORITHMIC DETAILS
The MLP was implemented with default parameters in Weka
(Bouckaert et al., 2010). All input features were normalized to
values between negative and positive 1. No limit was set on the
number of hidden layers or nodes within each hidden layer. These
parameters were optimized within each training set indepen-
dently. The learning rate and momentum were set to 0.3 and 0.2,
respectively. Five hundred epochs were used for training. Dur-
ing training, models with more than 20 consecutive errors were
excluded. The trinary classifier was created by decomposing the
three class problem into three 1-against-1 problems that were com-
bined using majority voting. No three-way ties occurred during
training or testing.
Balanced accuracy was optimized using a cost-sensitive classi-
fier in which a false positive was given a cost of n+ and a false
negative was given the cost of n−, where n+ and n− represent the
number of PWE and NES in the full sample, respectively. In the
trinary classifier, the cost was set as the sum of the number of
patients in the other two diagnostic classes.
Cyclical leave-one-out cross-validation (CL1OCV) was used to
assess the performance of the MLP. In this paradigm, all but one
patient was used to determine the features selected and train the
algorithm. The single remaining patient is tested using the model
built upon the other patients. The identity of the test patient is
permuted until all patients have been the test case once and only
once.
To determine the number and identity of the input features, the
mRMR algorithm requires the number of input features, F, and
quantal levels,Q,be setapriori.For the calculation of mutual infor-
mation, the features were smoothed intoQ quantal bins akin to the
bins in a histogram. Classification, however, utilizes unsmoothed
features. The choice of input features smoothed into quantal levels
was determined to be most representative of the performance of
the algorithm across a wide variety of choices of F and Q (Kerr
et al., 2012b). This choice was made by selecting a point within a
region of F-Q parameter space that performed significantly better
than the naïve classifier with 95% confidence based on random
field theory correction where the spatial smoothness is estimated
directly from the data (for more details, see Worsley et al., 1992,
2004; Chauvin et al., 2005). The naïve classifier classifies all test
exemplars as the most common class in the training set. Under the
CL1OCV procedure, these input features were determined inde-
pendently for each of the training samples. The illustrated rank
order of features was calculated based on the full dataset, and
does not necessarily match the rank list of any individual training
sample.
When clinical information was incorporated into the algo-
rithm, the same methodology was applied as above, except that all
exemplars with missing data were excluded from analysis. In these
additional analyses, we did not re-sample the parameter space of F
and Q. We simply used the selections determined in the previous
analysis.
MANUAL ANALYSIS OF PET AND MRI RECORDS
Manual analyses of the iPET and sMRI records were performed
based on the review of clinical records primarily written by Dr.
Noriko Salamon. Dr. Salamon has 10 years of experience in the
pre-surgical assessment of epilepsy using FDG-PET and MRI. All
manual interpretation was conducted for the clinical assessment
of each patient when it occurred, prior to the CAD tool devel-
opment. Therefore, Dr. Salamon was blinded to the automated
results. Due to the unclear relationship between structural and
metabolic abnormalities, asymmetries, and epilepsy, all abnor-
mal results were interpreted to be consistent with some form
of epilepsy. Not all patients had sMRI (n= 6) and iPET (n= 1)
reports available; therefore all analysis regarding MA of neu-
roimaging includes only patients with available records. These
patients had raw iPET data available; they therefore were included
in the automated analysis.
COMBINATION OF CLINICAL INFORMATIONWITH COMPUTER-AIDED
DIAGNOSTIC INFORMATION
To examine the combined power of clinical knowledge, MA and
our automated analysis, we assessed the linear correlation of
detecting epilepsy with CAD compared to MA, and also incorpo-
rated clinical information and MA into our algorithm in two ways.
First, the clinical literature suggests that patients with NES are
more likely to be female, begin having seizures in the third decade
of life, have a decreased duration of disease and have increased
seizure frequency (Table 1). Although we did not see a significant
difference seizure frequency within our dataset, we included this
features to better match clinical practice. These clinical features
were then added to the input and leave-one-out cross-validation
was repeated. Secondly, to explore how our computational meth-
ods can complement clinical wisdom, we included the results of
MA of the iPET and sMRI as two additional input features and
re-evaluated CAD performance. For the trinary classifier only, we
split each of the features describing the iPET and sMRI MA to
indicate if a left and/or right sided abnormality was reported.
To assess the applicability of our CAD as a separate modal-
ity that could be considered as part of the clinical assessment
of epilepsy, we calculated the likelihood ratios (LRs) of each of
the combinations of our CAD with MA of iPET and/or sMRI.
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Table 1 | Clinical information and results of manual analysis.
NES LTLE RTLE
Age Mean±SD 37±14* 38±12 36±13¶
Min-Max (Median) 16–76 (38) 18–54 (40) 17–67 (35)
N 32 39 34
Sex % Female±SE 78.1±7.3*§ 53.8±8.0 35.3±8.2
Duration of disease Mean±SD 12±12*§ 22±15 20±13
Min-Max (Median) 10 d–40 y (7) 6 m–53 y (21) 2 y–48 y (19)
Seizure frequency Mean±SD 3.2/d±5.9/d 1.2/d±2.4/d 1.5/w±1.7/w
Min-Max (Median) 0.3/m–25/d (3/d) 0.2/m–11/d (1/w) 0.1/m–1/d (0.8/w)
iPET manual % Positive±SE 18.8±6.9*§ 76.9±6.7 87.9±5.7
N 32 39 33
sMRI Manual % Positive±SE 34.5±8.8*§ 73.7±7.1 87.5±5.8
N 29 38 32
This table reflects the clinical information known before the application of the CAD tool. All times are listed in years (y) unless otherwise specified by days (d), weeks
(w), or months (m). Manual analysis of all patients’ iPET and sMRI were not done, therefore we list the number with available manual results. *, §, or ¶ indicate that
the value for NES vs. LTLE, NES vs. RTLE, or LTLE vs. RTLE, respectively, is statistically significant from both the LTLE and RTLE groups with at least 95% confidence
using a two-sample z-test of proportions or Mann–Whitney U test, where appropriate. No other differences are statistically significant (p>0.10).
This was done only for the binary classifiers, because LRs have a
clear formulation only for binary outcomes. The likelihood ratio
is defined by the likelihood that a patient with a certain combina-
tion of diagnostic outcomes has epilepsy, divided by the likelihood
that the same patient has NES. Intuitively, a likelihood ratio of two
implies that the patient is twice as likely to have epilepsy. The
95% confidence intervals of chance were calculated using exact
binomial intervals by considering the likelihood ratio of a clas-
sifier that diagnosed patients according to their prior likelihood
alone, conditioned upon the assumption that the same total num-
ber of patients would have the diagnostic outcome of interest.
For example, 39 of 71 patients had LTLE when we discriminated
between LTLE and NES, therefore the median LR is 1.2. Thirty-five
patients from the NES vs. LTLE group had negative MA of their
iPET. Therefore, we use a binomial distribution with 35 trials and
success probability of 39 over 71 to yield a 95% confidence interval
of 0.94–3.38.
RESULTS
All of our results are compared to the gold standard diagnosis
from the consensus panel. The clinical trial statistics of each of our
automated diagnostic tool matched, but were not redundant with,
expert MA of both interictal PET and sMRI (Figure 1). All inter-
vals reflect 95% confidence intervals and all p-values correspond
to differences from anaïve classifier. The binary CAD tool for
RTLE had accuracy of 88% (69–90%), compared to the accuracy
of MA of iPET [85% (72–92%)] and sMRI [77% (63–85)]. The
binary tool for LTLE had accuracy of 83% (69–90%), compared to
the accuracy of MA of iPET [79% (66–88%)] and sMRI [70%
(56–81%)]. The pattern in sensitivities, specificities, and odds
ratios all parallel this trend where our automated diagnostic tools
are non-statistically superior to MA oriPET, which, in turn, are
non-statistically superior to MA of sMRI (Figure 1). The accuracy
of our trinary CAD tool that simultaneously diagnoses epilepsy
and lateralize disease was 76% (66–84%), where 89% (77–96%)
of patients correctly identified with epilepsy were also lateralized
correctly. MA to diagnose and lateralize was 78% (69–86%) accu-
rate with 89% (76–94%) correctly lateralized using iPET and 71%
(61–80%) accurate with 91% (78–97%) correctly lateralized using
sMRI.
The rank order of the features used in our algorithm parallel
the clinical observation that the epileptogenic networks in LTLE
are broader than in RTLE. The LTLE vs. NES classifier achieved its
performance by utilizing trends across almost the entire brain by
including 42 of the 47 features in the final algorithm. In contrast,
the RTLE vs. NES classifier only needed to measure the metabo-
lism in six regions – bilateral temporal cortex and two associated
regions of cortex – to achieve its impressive performance (Table 2).
As expected, the trinary classifier utilized an intermediate number
of features to achieve its accuracy (30 of 47). The rank list of
these features matches the biological intuition based on knowl-
edge about the potential connectivity of epileptogenic networks
(Table 2).
We then considered how this CAD information could be used
in combination with clinical information or expert analysis. The
squared correlation of our CAD tool with manually interpreted
iPET was 0.25 (0.09–0.43), 0.32 (0.17–0.54), and 0.34 (0.17–0.46)
for the LTLE, RTLE, and trinary classifiers, respectively (Figure 2).
The squared correlation of our tool with manually interpreted
sMRI was 0.07 (0.001–0.23),0.21 (0.06–0.40),and 0.11 (0.02–0.25)
for the LTLE, RTLE, and trinary classifiers respectively. For com-
parison, the squared correlation between manually interpreted
iPET and sMRI was 0.17 (0.06–0.33).
When the same automated analysis was used to combine
clinical findings with our iPET data, performance did not change
significantly. After the four clinical factors were added to the input
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FIGURE 1 | CAD tool performance matches manual analysis. These
figures indicate the accuracy, sensitivity and specificity of the LTLE (A),
RTLE (B) and trinary (C) classifiers. The performance of our CAD tools
matched that of MA and was superior to just using gender alone. The error
bars indicate standard error of the mean performance for each measure.
The translucent region indicates the performance of a naïve classifier.
*Indicates significant differences from the naïve classifier with a confidence
level of 95% or more.
of our tools, the accuracy changed to 79% (66–88%), 68% (56–
79%), and 64% (54–73%) for the LTLE, RTLE, and trinary classi-
fiers, respectively (Figure 3). These accuracies do not substantively
Table 2 | Ranked list of contributing metabolic ROIs.
Region of interest
mRMR rank LTLE vs. NES RTLE vs. NES Trinary
1 Midbrain R ila temporal C R ila temporal C
2 L ilp temporal C R ilp temporal C L ilp temporal C
3 R ilp temporal C L sensorimotor C L sensorimotor C
4 L associative visual C L sl temporal C R ilp temproal C
5 L Broca’s Region R thalamus R sl temporal C
6 L s frontal C R i frontal C R pm temporal C
This table illustrates the top six informative and non-redundant regions of inter-
est (ROIs) that may contribute to each of the CAD tools, as determined by the
minimum redundancy-maximum relevancy criteria (mRMR; Ding and Peng, 2005;
Peng et al., 2005). The illustrated rank order of features was calculated based on
the full dataset and does not necessarily match the rank list of any individual
training sample. The leading L or R indicates left or right. The lowercase letters
indicate inferior (i), lateral (l), median (m), anterior (a), and posterior (p).The lagging
C signifies cortex. Note that the LTLE vs. NES and trinary classifiers include infor-
mation from 42 and 30 ROIs, respectively. To better understand the benefit of
mRMR, this list can be directly compared to the list of ROIs ranked by t-statistics
inTable A1 in Appendix.
FIGURE 2 | CAD tool is not redundant with manual analysis. The
squared correlation of our CAD tools’ results with those of MA of the iPET
or sMRI from the same patients was below 50%. This indicates that while
some information is shared, the majority of information provided by our
CAD tools is not captured by MA. The correlation between MA of iPET and
sMRI is similar in magnitude to the correlation of CAD with MA, therefore
the CAD could potentially be seen as similar to another informative
modality. *Indicates significant differences of the correlation from zero with
a confidence level of 95% or more.
change when only sex and duration of disease were considered
(results not shown). Adding the results of MA of both iPET and
sMRI to our iPET data changed the accuracy to 82% (73–91%),
77% (67–88%), and 68% (59–77%) for the LTLE, RTLE, and
trinary classifiers, respectively. When all information sources con-
tribute to the algorithm, the accuracy changed to 77% (68–88%),
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FIGURE 3 | Automated combination of clinical information with
automated analysis of iPET images. The automated combination of
clinical information and/or MA with our analysis produced no significant
change in performance for the LTLE (A), RTLE (B) or trinary (C) classifiers,
relative to the CAD operating on automated values alone. The unshaded
bars indicate the performance of similarly constructed CAD tools using
clinical information or the results of MA alone. The shaded bars indicate the
modified performance when information from NeuroQ is added. The
horizontal line indicates the mean accuracy of each CAD tool without
clinical information. The translucent region indicates the performance of a
naïve classifier.
74% (64–85%), and 76% (68–84%) for the LTLE, RTLE, and
trinary classifiers, respectively.
We combined the results of MA were combined with our CAD
tool manually using LRs. After doing so, the likelihood was gen-
erally only significant if all considered modalities agreed. Viewed
alone, MA and our CAD increased the likelihood of the predicted
outcome between two and ninefold (p< 0.02; Figure 4A). When
two analysis streams were combined, if both analyses agreed, the
likelihood of the predicted outcome was increased between 8- and
27-fold (p< 3× 10−4; Figures 4B,C). If all three analyses agreed,
the likelihood of the predicted outcome increased more than 15-
fold (p< 1.3× 10−5; Figure 4D). However, in most cases, if there
was any disagreement, the likelihood did not change significantly,
most probably due to the small numbers of patients with each
potential outcome. There are two key exceptions: (1) Given iPET
results indicating NES over RTLE using either MA or CAD, the
sMRI could be largely ignored (p< 1.1× 10−2). (2) If both MA
and CAD of iPET agreed that a patient suffered from LTLE and not
NES, the sMRI results could be similarly ignored (p< 3.3× 10−2).
DISCUSSION
These results demonstrate how our CAD tool has the potential
for clinically application, while also confirming and elucidating
the distributed effects of epilepsy on the entire brain. Our CAD
tool’s diagnostic performance of TLE matches, but is not redun-
dant with, expert MA of iPET and sMRI. When considered in
the context of recent reports of CAD tools for epilepsy based on
sMRI and interictal EEG data (Farid et al., 2012; Focke et al., 2012;
Keihaninejad et al., 2012; Kerr et al., 2012a), CAD is proving espe-
cially applicable to epilepsy. Further, if more work confirms the
hypothesis that metabolic changes in iPET are observable before
the structural changes in sMRI, our iPET tool may have better
clinical utility than these existing sMRI tools. In contrast to MA,
this and other CAD tools can be quickly and efficiently applied
by minimally trained technicians, emergency physicians, and pri-
mary care providers as preliminary analysis of the iPET images
(van Ginneken et al., 2011; Kerr et al., 2012c). The performance
of MA can vary with experience and fatigue of the observer; auto-
mated tools are consistent over time. Upon further validation,
these CAD results could also be incorporated into the consensus
diagnoses with minimal cost if iPET already has been obtained.
CLINICAL IMPACT
Our CAD tools could provide valuable clinical information that
may help readily identify which treatments may be effective
in patients who present with uncharacterized, and/or medica-
tion refractory seizures (Kerr et al., 2012a,c). In particular, 15
of our 105 patients were admitted twice to achieve definitive
characterization or localization of their seizures. The appropriate
binary classifier correctly diagnosed 12 (80%) of these challeng-
ing patients. This valuable information might reduce the need
for multiple video-EEG admissions. Additionally, 28% (9/32)
of our PWN were admitted for improved characterization of
their previously-diagnosed “epilepsy,” and 16% (12/73) of our
PWE were admitted for the differential diagnosis of epilepsy,
indicating that non-epileptic etiologies were not ruled out suf-
ficiently. The trinary CAD effectively diagnosed 67% (14) of these
www.frontiersin.org April 2013 | Volume 4 | Article 31 | 7
Kerr et al. Quantitative FDG-PET diagnosis of epilepsy
FIGURE 4 | Combination of clinical information and CAD results using
likelihoods. Columns in this log plot above 1 indicate that the seizures are
more likely to be epileptic whereas the columns below 1 indicate a
non-epileptic etiology is more probable. (A) Illustrates the positive and
negative likelihood ratio of each analysis method considered individually.
(B,C) Illustrate the likelihood ratios of each possible outcome when two
analysis methods are combined. (D) Indicates the likelihood ratios of each
possible outcome when all analysis methods are combined. If all
modalities agree, the likelihood non-significantly increases with the
addition of each modality. However, if there is disagreement, the likelihood
ratio is generally not significantly different from chance. The translucent
bars indicate the 95% confidence interval for chance with the relevant sign
(see Materials and Methods).The numbers above the translucent bars
indicate the total number of patients with each outcome. The bars that go
off the scale of the graph diverge toward zero or infinity because no
patients of a certain class had that outcome. *Indicates significant
differences of the correlation from zero with a confidence level of 95%
or more.
particularly challenging patients. Despite this impressive perfor-
mance, the ultimate goal of CAD, however, is to complement – not
replace – MA.
COMBINATION OF AUTOMATED ANALYSIS WITH CLINICAL WISDOM
Our finding that performance almost uniformly, but non-
statistically, decreased when the automated algorithm incorpo-
rated clinical information indicates that automated analysis can-
not and should not replace manual interpretation across infor-
mation modalities. We suspect that this performance decreased
due to ineffective modeling of the contribution of the clinical
information and over-fitting. The statistical distribution of the
clinical factors was very different from the metabolic data therefore
the same model likely cannot effectively utilize both modalities.
The efficient incorporation of multimodality information into
machine learning is an active area of theoretical research, and well-
validated methods are not yet available. Now that CAD tools using
interictal EEG (Kerr et al., 2012a), sMRI (Farid et al., 2012; Focke
et al., 2012; Keihaninejad et al., 2012), and iPET have been pub-
lished, we believe it will be extremely exciting to assess how these
various tools can be combined.
We expected that the best performance would be achieved when
our CAD is used synergistically with MA. The low correlations
between the CAD results and MA suggest that our CAD tool pro-
vides information that is not evident on visual inspection. These
results emphasize that PET is not redundant with MRI (Henry
et al., 1999). Physicians could learn to view CAD as analogous
to another imaging modality that provides valuable, but not per-
fectly diagnostic, clinical insight. This synergistic application of
computer-aided diagnosis after manual interpretation already has
proven beneficial in the detection of lung nodules by the FDA
and is an active area of translational research (Kerr et al., 2012c;
Wang et al., 2012). The key differences between MA and auto-
mated analysis are the ability to entirely ignore certain pieces of
data, and to rule that the results are inconclusive.
The results summarized above, and the LRs for each analy-
sis stream individually, show that both MA and CAD are useful
clinically. If the analysis streams agree, the diagnostic certainty
increases substantially, but at a cost: as more analyses are added,
more patients have inconclusive results because the analyses did
not agree, and the LRs are not significant. Even though our sample
size is large compared to other studies of this type, there were not
enough patients in our dataset with each diagnostic outcome to
explain the clinical implication of disagreeing analyses adequately.
This matter of inconclusive results is a common challenge faced in
clinical practice. Physicians struggle regularly with those types of
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decisions. When MA of iPET and sMRI are combined, they need to
agree to yield meaningful results. However, our analysis shows that
in some specific cases, if both the MA and CAD of iPET agree, the
sMRI is not needed. This parallels the finding we suggested above:
iPET may be more clinically useful than sMRI to diagnose and lat-
eralized epilepsy. The hypometabolic abnormality may be present
earlier in disease (Theodore et al., 1990; Ryvlin et al., 1991; Swartz
et al., 1992; Gaillard et al., 1995; Debets et al., 1997; Knowlton
et al., 1997, 2008; Blum et al., 1998; Drzezga et al., 1999; Benedek
et al., 2004; Carne et al., 2004; Chandra et al., 2006; Yun et al., 2006;
Uijl et al., 2007; Willmann et al., 2007; Rastogi et al., 2008; Sala-
mon et al., 2008; Duncan, 2009; Lee and Salamon, 2009; Lerner
et al., 2009; Liew et al., 2009; Brodbeck et al., 2010; Chinchure et al.,
2010; Kim et al., 2011; Jupp et al., 2012), and it may provide slightly
more accurate disease characterization, as seen in our dataset. In
settings where the PET scanner is not combined with the MRI
scanner, and/or when the cost of imaging is a limiting factor (both
common occurrences) the effective application of our CAD could
result in substantial cost savings.
PATHOPHYSIOLOGICAL INSIGHTS
Our methods also reveal a potential difference in the pathophysi-
ology of left vs. right TLE. This may help explain why CAD tools
perform slightly better when diagnosing RTLE compared to LTLE
(Farid et al., 2012; Focke et al., 2012; Keihaninejad et al., 2012).
The finding that mostly bilateral temporal ROIs, the right inferior
frontal cortex and left sensorimotor cortex provide non-redundant
diagnostic information for RTLE is consistent with the clinical wis-
dom that the epileptogenic network in RTLE is more focal than
in LTLE. The inclusion of temporal regions echoes the conven-
tional wisdom that focal hypometabolism and asymmetry reflect
characteristic changes due to epilepsy. This suggests that conserva-
tive resection of the temporal lobe may result in increased rates of
seizure freedom in RTLE compared to LTLE due to complete resec-
tion of the SOZ. Further, seizures that originate in the left temporal
lobe may secondarily generalize more frequently in LTLE. These
differences have not yet been studied clinically.
The trends in the extratemporal regions included in the algo-
rithms suggest that the primary lesion may induce metabolic
changes in functionally or anatomically associated regions. This
is substantiated further by the finding that almost all regions of
the brain provide informative diagnostic information in LTLE.
This in turn mirrors the increased stereotypic connectivity of the
left temporal lobe. Even though the interconnectivity of the right
hemisphere is higher than the left hemisphere, the left hemisphere
has strong connections between specialized foci (Barrick et al.,
2005; Iturria-Medina et al., 2011; Kucyi et al., 2012). We hypoth-
esize that the SOZ may induce abnormal metabolism along these
strong, stereotyped connections. This change cannot be attrib-
uted to language specifically in our dataset because we did not
identify the laterality of language dominance in our patients.
Compared to our t -statistics ranking, it may seem surprising that
the metabolism of the midbrain was ranked first by mRMR for
LTLE vs. NES. This rank may indicate a non-linear change in
the metabolism within the dorsal midbrain anticonvulsant zone,
which has itself been identified in animals to be part of the net-
work that modulates seizure threshold (Shehab et al., 1995). The
exact relationship between epilepsy and midbrain metabolism is
unclear, however. The lack of distributed atrophy in LTLE mea-
sured by sMRI suggests that these changes are not associated with
distributed cell death or gliosis (Farid et al., 2012; Focke et al.,
2012; Keihaninejad et al., 2012). Instead, we hypothesize that this
change instead reflects abnormal metabolism in these regions due
to altered neural connectivity and/or activity secondary to the
epileptogenic lesion. This is supported by the finding that LTLE
was associated with more changes in functional connectivity than
RTLE was (Pereira et al., 2010). This also explains why we observed
metabolic changes in the right thalamus in RTLE: recent work
demonstrates that the connectivity of the right thalamus with the
right hippocampus is reduced in RTLE (Morgan et al., 2012). The
presence of such distributed changes also supports the finding
that the size of the hypometabolic lesion visualized on PET may
be larger than the SOZ (Juhasz et al., 1999; Matheja et al., 2001;
Henry and Roman, 2011). It is particularly interesting to note that
the extent of these distributed changes is underappreciated by t -
statistics comparing LTLE to NES. This indicates that there is a
complex, likely non-linear, relationship between the metabolism
of the hypometabolic lesion and its associated tissue that may be
better understood by mutual information.
The inclusion of the contralateral hippocampus in both of the
binary classifiers lends itself to multiple interpretations that are
all supported by biologically sound hypotheses. Firstly, a salient
feature of LTLE or RLTE could be asymmetric metabolism, as
suggested clinically; therefore the metabolism of the contralat-
eral hippocampus was compared to the observed metabolism in
the ipsilateral hippocampus. Alternatively, the interhemispheric
connectivity between the hippocampi is high, therefore under
our hypothesis that changes in metabolism spread according to
functional connections, the metabolism in the contralateral hip-
pocampus may be one of the first induced changes due to the
epileptic lesion. Lastly, if LTLE and RTLE are inherently bilateral
diseases then the metabolism in the contralateral hippocampus
may also be abnormal. This also provides an explanation for why
LTLE and RTLE were not perfectly distinguished.
In addition to diagnosing epilepsy, our algorithm lateralized
disease efficiently with an accuracy of approximately 90% when
epilepsy was diagnosed correctly. This impressive accuracy could
be clinically useful for pre-surgical planning, when used in combi-
nation with other clinical and radiological information. Although
our current sample size is too small to fully assess this potential
fully, our results suggest that similar methodology could be applied
to a larger dataset with more diverse and specific SOZ localiza-
tions to yield an objective and reliable tool to assist in pre-surgical
SOZ localization. Our data suggest that this approach likely would
identify and utilize distributed metabolic findings associated with
each epileptic lesion to improve performance. Instead of blur-
ring the boundary of the SOZ by detecting affected tissue outside
the SOZ, the improved understanding of these distributed effects
may lead to more refined characterization of this clinically vital
SOZ. However, the spatial resolutions of our outcome classes were
insufficient to assess the utility of this method directly to identify
candidate lesions for resective surgery.
While our lateralization accuracy is exciting, there is also
a potential clinical interpretation of the patients who were
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falsely-lateralized. Functional connectivity between the temporal
lobes is particularly strong. In a minority of patients, this con-
nectivity allows epileptogenic activity to spread quickly from the
SOZ to the contralateral temporal lobe on EEG, resulting in the
appearance of either bilateral or falsely-lateralized disease. Simi-
larly to the distributed networks discussed above, this high degree
of functional connectivity also may induce metabolic abnormali-
ties in the contralateral temporal lobe that may be indistinguish-
able from the primary lesion. This hypothesis can be tested by
comparing these falsely-lateralized patients to patients with bilat-
eral TLE. This comparison requires a detailed methodological
treatment of non-mutually exclusive classes in machine learning
and therefore lies outside the scope of the current manuscript.
To characterize these and other pathophysiological insights,
most studies utilize healthy neurologically normal controls. In
contrast, we prefer the use of PWN as our control group. In brief,
when constructing a control group, one aims to match the patients
in the pathologic group in all aspects other than the pathology.
In contrast to neurologically normal controls when compared to
PWE, PWN’s have been exposed similarly to AEDs and other med-
ications, have increased prevalence of TBI and some other risk
factors for epilepsy (Sahaya et al., 2011), have regular and frequent
meetings with health care providers, and have much more strict
inclusion criteria. Lastly, and perhaps most importantly,physicians
do not consider whether all of their patients have epilepsy; they
assess only the patients with seizures. Therefore, in our opinion,
the use of PWN as the control group is a benefit in of our study
because it maximizes the clinical relevance of our results while
simultaneously improving its statistical selectivity.
LIMITATIONS AND FUTURE DIRECTIONS
Because our retrospective dataset was collected as part of clinical
care, our approach has a few important limitations. The accuracy
of MA reported in our patients is worse than the rates quoted
in previous literature (Rastogi et al., 2008; Salamon et al., 2008;
Lee and Salamon, 2009). Given UCLA’s status as a tertiary refer-
ral center, the decrease in manual accuracy likely indicates that
our patients had more heterogeneous etiologies and/or were more
complex and difficult to diagnose than other centers. This sug-
gests that our CAD tool may perform better on other datasets. Our
iPETs and MRIs were collected on varying cameras with varying
resolutions. This demonstrates the flexibility of our automated
analysis using NeuroQ. The efficacy of the MA of older and lim-
ited resolution data may not be comparable to that of more current
and higher resolution data. After establishing the efficacy of our
method, we plan to both validate our tool prospectively on data
from other centers, and to incorporate multi-center data into our
algorithm to further improve its performance. Additionally, we
only discuss the combination of CAD results with independently
derived MA. Future work will examine the efficacy of CAD tools
informed by MA and vice versa.
Critics of our approach might claim that the significant gender
and age difference of the patients with NES compared to PWE
may lead to our CAD simply detecting the age and/or gender of
the patients. While we do not expect this to be the case for RTLE,
the utilization of language areas by the LTLE classifier might reflect
differences in gender, and not epileptogenic pathology. However,
the performance of our CAD was significantly higher than when
clinical information was used directly, therefore the algorithm
utilized more information than just clinical data to achieve its
strong performance. These significant differences in clinical fac-
tors largely mirror the observed differences in clinic; therefore our
dataset better matches the population for which our CAD tool
would be applied. The only notable exception is the significant age
difference between LTLE and RTLE, which was unexpected. Due
to the naturalistic nature of our data collection scheme, we did not
correct for this difference. However, we note similarly to the NES
group, the use of age alone was significantly worse than our tool
and the addition of age to the iPET data to control for its effect
did not significantly change performance.
Another key caveat to the direct clinical application of our tool
to clinical practice is the fact that epilepsy is an extremely het-
erogeneous disease. The generalization of our method to bilateral
TLE, extratemporal foci and multifocal epilepsy will be critical
before it can be incorporated into clinical practice. In particular,
even though NES mimic all types of seizures, it is uncommon
for TLE to be mistaken for NES. Instead, it is more common
that NES appear to have a focus in frontal cortex (LaFrance and
Benbadis, 2011). Therefore, the literature suggests that the high-
est impact CAD tool would discriminate between frontal lobe
epilepsy and NES and another, separate tool could be used to
lateralize TLE. Based on our results above (see section Clinical
Impact), we believe that our TLE-specific tool may be clinically
applicable. For the first publication demonstrating the applica-
bility of computer-aided diagnosis based on iPET data, we chose
to focus on the diagnosis and lateralization of TLE, based, based
on prior findings that the sensitivity of iPET is highest for TLE.
Our future work then can address generalizing our methods
to the other epilepsies, including bilateral TLE and frontal lobe
epilepsy.
CONCLUSION
Despite a few caveats, and upon further validation with data from
other centers, our automated methods could provide unique infor-
mation for the effective and efficient characterization of epilepsy,
with the potential to decrease the fraction of patients with NES
that are being treated (inappropriately) with AEDs, and to more
quickly triage patients with medication refractory epilepsy toward
surgical intervention. This may help achieve the ultimate goal: a
global reduction in seizures (Engel et al., 2012).
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APPENDIX
Table A1 |This table illustrates the ranking of informative regions of
interest (ROIs) based on the maximum magnitude of t -statistic
across the three contrasts.
Region of interest LTLE vs. NES RTLE vs. NES LTLE vs. RTLE
Lilp temp C −3.974*** 0.158 −3.410**
Lila temp C −3.493** 0.410 −3.463***
L sensorimotor C 0.230 3.459*** −2.469*
Rila temp C 0.080 −3.441** 3.172**
Rpm temp C 2.583* −1.147 3.266**
Rs parietal C 3.202** 0.631 2.229*
R assoc. visual C 2.641* −1.128 3.180**
Rsl temp C 1.450 −2.343* 2.995**
Lam temp C −1.349 1.415 −2.981**
Ram temp C 2.176* −1.234 2.986**
Ri parietal C 2.975** 1.266 2.072*
R parietotemporal C 2.246* −0.325 2.720**
Ls frontal C −1.828 0.545 −2.389*
Rilp temp C 0.447 −2.321* 2.361*
La cingulate C 1.274 2.320* −1.021
L thalamus −1.663 −0.192 −2.236*
Lpm temp C −1.212 1.069 −2.189*
Ri frontal C −0.742 −2.172* 1.409
Lsl temp C −1.664 1.000 −2.163*
L lentiform nucleus −1.115 1.399 −2.032*
Lm frontal C −1.949 0.244 −2.001*
Li frontal C −1.930 0.059 −1.971
Ls frontal C 1.536 −0.351 1.943
Rm frontal C 1.482 −0.280 1.807
Rm frontal C 0.878 −0.883 1.726
Rp cingulate C 0.034 −1.215 1.712
R sensorimotor C 1.629 0.989 0.750
Li parietal C 1.576 1.361 0.193
(Continued)
Region of interest LTLE vs. NES RTLE vs. NES LTLE vs. RTLE
R Broca’s region 1.108 −0.442 1.570
R caudate nucleus 1.462 0.925 0.559
L caudate nucleus −0.937 0.599 −1.460
L Broca’s region −1.028 0.668 −1.427
R primary visual C −0.237 −1.362 1.393
Lm frontal C 1.096 1.370 −0.291
Ra cingulate cortex 1.286 0.407 0.889
R thalamus 0.266 −0.944 1.282
R lentiform nucleus 0.947 0.442 0.271
L primary visual C −0.944 −0.149 −0.810
L assoc visual C −0.142 −0.861 0.660
Vermis −0.197 0.507 −0.701
Pons 0.667 0.473 0.153
L parietotemporal C −0.569 −0.530 −0.028
R cerebellum −0.087 0.406 −0.535
Lp cingulate C −0.211 −0.498 0.393
L cerebellum −0.461 −0.321 −0.054
Midbrain −0.383 0.100 −0.435
Ls parietal cortex 0.093 0.195 −0.096
Negative t-values in the first two columns indicate the hypometabolism in
epilepsy. Negative t-values in the last column indicate hypometabolism in LTLE
compared to RTLE. The leading L or R indicates left or right. The lowercase let-
ters indicate inferior (i), lateral (l), median (m), anterior (a), and posterior (p). The
lagging C signifies cortex. Bold indicates significant differences at greater than
the 95% confidence level. The markings of *, **, and *** indicate significance
at the 95, 99, and 99.9% confidence level, respectively, without multiple testing
correction. No t-statistics remain significant at the 95% confidence level after
Bonferroni correction.
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